Keyphrases
Meta-analysis
100%
Confidence Interval
53%
Myocardial Infarction
49%
Dual Antiplatelet Therapy
47%
Systematic Meta-analysis
44%
Randomized Controlled Trial
43%
Atrial Fibrillation
33%
Cardiovascular Mortality
33%
Drug-eluting Stent Implantation
32%
Drug-eluting Stent
32%
All-cause Mortality
28%
Odds Ratio
26%
Percutaneous Coronary Intervention
25%
Meta-analysis of Randomized Controlled Trials
25%
Stent Thrombosis
24%
Transcatheter Aortic Valve Replacement
24%
Relative Risk
20%
Heart Failure
20%
Acute Coronary Syndrome
18%
Body Mass Index
18%
In-hospital Mortality
17%
Embase
16%
Random Effects Model
15%
Major Bleeding
15%
Event Rate
14%
Risk Ratio
14%
Coronary Artery Disease
14%
Coronary Revascularization
13%
Vorapaxar
13%
Right Ventricular Function
13%
Left Ventricular Function
13%
Surgical Aortic Valve Replacement
12%
High Risk
12%
Randomized Clinical Trial
12%
ST-elevation Myocardial Infarction (STEMI)
12%
Cardiac Resynchronization Therapy
12%
Acute Myocardial Infarction
12%
Long Follow-up
12%
Infective Endocarditis
12%
Ischemic Mitral Regurgitation
12%
Diabetic
12%
Antithrombotic Therapy
12%
Network Meta-analysis
12%
Transcatheter Aortic Valve Implantation
12%
Implantable Defibrillator
12%
Niacin
12%
Clinical Application
12%
Current Clinical Practice
12%
PubMed
10%
Cardiac Mortality
10%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
59%
Randomized Controlled Trial
58%
Antiplatelet
56%
Congestive Heart Failure
39%
Atrial Fibrillation
33%
Cerebrovascular Accident
31%
Cardiovascular Mortality
25%
All Cause Mortality
22%
Bleeding
22%
Mitral Valve Regurgitation
20%
Combination Therapy
20%
Stent Thrombosis
19%
Coronary Artery Disease
15%
Random Effects Model
15%
Acute Coronary Syndrome
14%
Obesity
13%
Vorapaxar
13%
Brain Ischemia
13%
Anticoagulant Agent
13%
Randomized Clinical Trial
12%
Acute Heart Infarction
12%
Diabetes Mellitus
12%
Bisphosphonic Acid Derivative
12%
Nicotinic Acid
12%
Observational Study
11%
Hospital Mortality
11%
Diseases
10%
Implant
9%
Aortic Stenosis
9%
Underweight
8%
Placebo
8%
Deep Vein Thrombosis
8%
Cardiovascular Disease
8%
Biological Marker
8%
ST Segment Elevation Myocardial Infarction
7%
Adverse Event
7%
Cause of Death
7%
Valvular Heart Disease
6%
Monotherapy
6%
Prevalence
6%
Brain Hemorrhage
6%
Rivaroxaban
6%
Prasugrel
6%
Heart Death
6%
Takotsubo Cardiomyopathy
6%
Ischemic Mitral Valve Regurgitation
6%
Bacterial Endocarditis
6%
Varenicline
6%
Pharmacotherapy
6%
Protamine
6%
Medicine and Dentistry
Meta-Analysis
68%
Systematic Review
36%
Congestive Heart Failure
36%
Myocardial Infarction
34%
Percutaneous Aortic Valve Replacement
33%
Drug-Eluting Stent
31%
Odds Ratio
27%
Antiplatelet
26%
Mitral Insufficiency
24%
Randomized Controlled Trial
22%
Atrial Fibrillation
20%
Coronary Artery Disease
16%
Apoplexy
16%
Cardiovascular System
15%
Surgical Risk
15%
Aortic Valve Replacement
12%
Antithrombotic
12%
Cardiac Resynchronization Therapy
12%
Infective Endocarditis
12%
Right Ventricular Function
12%
Mitral Valve Repair
12%
Implantable Automatic Defibrillator
12%
Combination Therapy
11%
Stent Thrombosis
11%
Beta Adrenergic Receptor Blocking Agent
10%
Ejection Fraction
10%
Cardiovascular Mortality
9%
Percutaneous Coronary Intervention
9%
Ischemic Heart Disease
9%
Cardiac Magnetic Resonance Imaging
9%
Acute Coronary Syndrome
9%
Bleeding
9%
Surgery
9%
Hospital Mortality
8%
Echocardiography
8%
Valvuloplasty
8%
Random Effects Model
7%
Heart Muscle Revascularization
7%
All Cause Mortality
7%
Valve Replacement
7%
Vorapaxar
7%
Anticoagulation
7%
Biological Marker
6%
Aortic Insufficiency
6%
Valvular Heart Disease
6%
Aortic Pressure
6%
Mitral Valve Surgery
6%
Blood Transfusion
6%
Hypokalemia
6%
Vulnerable Plaque
6%
